vimarsana.com
Home
Live Updates
Preliminary Results from Two Clinical Studies of Selinexor t
Preliminary Results from Two Clinical Studies of Selinexor t
Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
Related Keywords
Australia ,
Louisiana ,
United States ,
Taiwan ,
New Orleans ,
Shanghai ,
China ,
Hong Kong ,
Singapore ,
Beijing ,
South Korea ,
American ,
Jay Mei ,
Asia Pacific ,
Peter Qian ,
American Society Of Hematology ,
Company Annual ,
Antengene Corporation ,
Hong Kong Stock Exchange ,
Antengene Corporation Limited ,
Plus Gemox Regimen ,
Heavily Pretreated Patients ,
Cell Lymphoma ,
Phase Ib Touch ,
Preliminary Results ,
Launch Study ,
Open Label Study ,
Refractory Multiple ,
Corporation Limited ,
Patients Beyond ,
Greater China ,
Annual Report ,
Hong Kong Stock ,